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Abstract
Background: The aim of this systematic review is to synthesize existing evidence about treatment satisfaction
among clients with substance misuse and mental health co-morbidity (dual diagnoses, DD).
Methods: We examined satisfaction with treatment received, variations in satisfaction levels by type of treatment
intervention and by diagnosis (i.e. DD clients vs. single diagnosis clients), and the influence of factors other than
treatment type on satisfaction. Peer-reviewed studies published in English since 1970 were identified by searching
electronic databases using pre-defined search strings.
Results: Across the 27 studies that met inclusion criteria, high average satisfaction scores were found. In most
studies, integrated DD treatment yielded greater client satisfaction than standard treatment without explicit DD
focus. In standard treatment without DD focus, DD clients tended to be less satisfied than single diagnosis clients.
Whilst the evidence base on client and treatment variables related to satisfaction is small, it suggested client
demographics and symptom severity to be unrelated to treatment satisfaction. However, satisfaction tended to be
linked to other treatment process and outcome variables. Findings are limited in that many studies had very small
sample sizes, did not use validated satisfaction instruments and may not have controlled for potential confounders.
A framework for further research in this important area is discussed.
Conclusions: High satisfaction levels with current treatment provision, especially among those in integrated
treatment, should enhance therapeutic optimism among practitioners dealing with DD clients.
Keywords: Dual diagnosis co-morbidity, integrated treatment, mental illness, satisfaction, substance misuse
Background
The evidence base regarding best practice for the treat-
ment of clients with co-occurrence of substance misuse
and mental health problems (dual diagnosis, DD)
remains ambiguous. While some studies have found
promising client outcomes after integrated treatment
(simultaneous care for both problem areas by the same
provider) [1-3], several systematic reviews have con-
cluded that the evidence remains inconsistent as to
whether integrated care is more effective than parallel
or sequential treatment approaches [4-10].
While most DD studies evaluate treatment effective-
ness in terms of improvements in clinical outcomes (i.e.
severity of substance misuse and/or psychiatric
symptoms), recent research has also started to focus on
client perceptions of treatment. Clients’ views towards
their care have been commonly subsumed under the
term of ‘treatment satisfaction’, which refers to “the
extent to which a programme is perceived as having
met an individual’s treatment wants and needs” (p. 456)
[11]. Examining client satisfaction can provide valuable
insights into treatment delivery by identifying the nature
and extent of unmet needs and expectations [12-15].
Client perceptions are increasingly recognised as an
important indicator of treatment quality with previous
research showing links between satisfaction, treatment
adherence, retention and clinical treatment outcomes
[16-23]. Recent treatment guidelines in both the mental
health and the addiction field list the improvement of
client satisfaction as a key target [24-26]. Taking into
account the ongoing uncertainty around best-practice
models for the DD population, clients’ own treatment
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perceptions about different care approaches may be
important in identifying potential problems in the qual-
ity of existing interventions and in informing future
treatment developments.
Objectives
The aim of this review is to synthesize existing evidence
about treatment satisfaction among DD clients. The fol-
lowing four key questions have guided the review:
1) How satisfied are DD clients with treatment they
receive?
2) Do satisfaction levels among DD clients differ
according to whether they receive integrated or standard
care?
3) Do DD clients report lower treatment satisfaction
levels compared to single diagnosis clients when treated
in the same clinical setting?
4) Do studies identify other factors related to treat-
ment satisfaction in DD clients?
Methods
Study inclusion criteria
We considered all quantitative studies that assessed
treatment satisfaction among adult clients with co-exist-
ing drug/alcohol misuse and mental health problems,
without placing restrictions on the clinical setting in
which the study was carried out or the type of diagnosis
procedure used. Studies were excluded if sample sizes
were smaller than N = 10, treatment provision com-
prised self-help groups only or was limited to a single
treatment session. Furthermore, studies had to provide
basic information about the satisfaction assessment used
and to report results of DD clients’ satisfaction ratings
separately from any other groups that may also have
been investigated. The electronic databases PsycInfo,
Medline, Academic Search Premier and ProQuest were
searched using pre-defined search strings to identify stu-
dies published in English-language peer-reviewed jour-
nals between January 1970 and October 2010 (see
Figure 1). Bibliographies and citation records of relevant
papers were also examined.
Selection of potentially relevant studies
Initially, search results (N = 2,093) were screened based
on study titles by the first author. Studies were excluded
if titles indicated that the focus was on populations with
other co-morbidities (e.g. two medical conditions) or
non-treatment contexts (n = 996, see Figure 2). Next,
abstracts of the remaining studies were examined (n =
1,097) to decide if a study met the inclusion criteria and
appeared to address at least one of the research ques-
tions. As a result, 969 studies were excluded based on
the information given in the abstract (e.g. small sample
size, participants younger than 18 years). The full text
article was obtained for 128 studies, which were sub-
jected to a more detailed analysis using a self-developed
data extraction form (available from the first author).
That is, relevant information (e.g. methods used for
assessing satisfaction, sample size, research questions
addressed) was extracted from each of the 128 articles
to determine their eligibility for the current review. In
order to avoid missing relevant studies, full texts were
also screened for DD-related articles where it was
unclear from the abstract whether treatment satisfaction
was assessed (e.g. range of outcome variables not fully
specified). At this stage, 101 studies were excluded
because they i) did not explicitly focus on both co-mor-
bidity and client satisfaction together (n = 71), ii) did
not separately report satisfaction levels among client
subgroups with DD problems (n = 13), iii) used qualita-
tive methods only (n = 6), iv) assessed client perceptions
but not treatment satisfaction explicitly (n = 6), and v)
did not provide sufficient detail about the satisfaction
instrument used (n = 5). Full citation details for these
studies are given in Additional File 1.
We assessed the quality of each of the remaining 27
studies selected for inclusion by critically appraising the
following aspects of its protocol based on existing guide-
lines [27]: study design (e.g. single vs. multiple satisfac-
tion assessment points), research instruments used
(standardised vs. non-standardised), adequacy of a
study’s sample size (e.g. power calculations mentioned)
and robustness of analytic approach (e.g. control
variables). Furthermore, we intended to include a meta-
analysis of those studies that address research question
2 and 3. However, due to the small number of studies
available, difficulties in the data preparation process (i.e.
statistics required for calculating effect measures were
missing in two articles), and high heterogeneity among
studies, we considered a quantitative synthesis of data
inappropriate for the current review.
Results
Description of included studies
Of the 27 included studies, 21 were conducted in the
US, four in the UK, one in Australia and one in
Dual diagnosis OR dual disorder 
OR co-morbid OR mentally ill 
chemical abuser OR chemically 
addicted mentally ill
(Mental OR psychiatric OR 
psychological health / illness / 
disorder / disease / problem) 
AND (substance OR drug OR 
alcohol OR addict)
(Client OR user OR patient OR 
consumer OR addict) AND 
(satisfaction OR perception OR 
feedback OR view OR 
engagement OR evaluation OR 
involvement)
or
+ +
Figure 1 Search terms used for electronic databases and other
sources.
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Honduras. All studies reported treatment satisfaction
ratings of DD clients (research question 1) and seven
studies compared such ratings by type of treatment
intervention provided (research question 2). Only three
studies could be found that investigated whether or not
satisfaction ratings differ among clients with or without
DD problems when treated in the same setting (research
question 3). Nine studies reported testing for links
between additional factors (e.g. client demographics)
and treatment satisfaction in DD clients (research
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:10.1371/journal.pmed1000097 
 
For more information, visit www.prisma-statement.org. 
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Figure 2 Study selection process.
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question 4). Of the 27 studies, two represented updates
or extensions of earlier studies conducted in the UK
[28,29] and the US [30,31]. In these cases, it was not
possible to establish the extent to which subject pools
overlapped, so both updated study reports were included
in the current review.
Sample sizes ranged from 17 to 2,729 clients (see Addi-
tional File 2). Most studies included clients with co-mor-
bidity only. Five studies compared satisfaction levels
between DD clients and those with either mental health or
substance misuse problems only [32-36]. Types of treat-
ment setting and interventions delivered varied greatly
across studies, ranging from residential psychiatric or
addiction services to forensic programmes and assertive
integrated treatment models (see Additional File 2).
Client profiles
The majority of participants were male. Four studies
included men only [36-39] and four others examined
women only [40-43]. The mean ages ranged from 30 to
45 years (SD = 6.3-14.0). Six US studies appeared to
recruit disproportionately more African-Americans than
Caucasians [30-32,37,44,45] whilst in eight other studies
Caucasian was the most common ethnic group
[35,40,46-51]. In the remaining studies, client ethnicity
was diverse. The sample studied by Aguilera et al. [38]
differed in ethnicity from all others due to its location
(Honduras). Five studies included homeless individuals
only [30,31,37,48,51] and two focused on clients
involved in the criminal justice system [39,47]. Informa-
tion about clients’ socio-demographics was incomplete
for a number of study reports [33,39,45,46,52,53].
Turning to the type of mental illnesses identified, 12
of the 27 studies mainly included clients who suffered
from schizophrenia-spectrum disorders or other severe
mental illnesses with psychotic features
[28-32,34,37,39,45,46,49,52]. Four studies investigated
participants with posttraumatic stress disorder or his-
tories of abuse in addition to mental health problems
[40-43] and another focused on personality disorders
[47]. The ten remaining studies reported affective or
anxiety disorders as the most common mental illnesses
[33,35,36,38,44,48,50,51,53,54].
In terms of substance use, 14 studies identified alcohol
as being the main substance of misuse
[28-31,33,36,40,47-52,54]. In two other studies cocaine
was the most common drug [44,45], in one study
methamphetamine [42] and in another cannabis [39].
Two studies described most participants as polydrug
users [37,38]. Seven studies did not include details about
clients’ primary substance [32,34,35,41,43,46,53].
Assessment of treatment satisfaction
Of the 27 studies identified, 13 reported the use of a
standardised instrument for assessing treatment satisfac-
tion (see Table 1 and Additional File 2). All but one of
these employed the Client Satisfaction Questionnaire
(CSQ-8) [55] either in its original form or with minor
modifications. In six of these 13 studies, additional
assessment instruments were adopted (e.g. Treatment
Perceptions Questionnaire) [11]. The remaining 14 stu-
dies did not employ standardised satisfaction measures
and used either single items asking clients about their
satisfaction with the overall treatment experience (n =
4) or multiple items covering several aspects related to
treatment delivery (n = 10).
More than half of the studies (n = 17) assessed clients’
treatment satisfaction at a single point in time only (see
Additional File 2). Of these, ten studies provided infor-
mation about the length of treatment stay when client
satisfaction was measured. The other ten studies
included in this review obtained satisfaction data repeat-
edly and at different treatment stages, ranging from
baseline to 36-month follow-up assessments.
How satisfied are DD clients with currently available
treatment options?
Clients consistently reported high average satisfaction
scores, which in some studies were close to the maxi-
mum score of the scales used, thus suggesting that on
the whole, clients tend to be satisfied with their treat-
ment (see Table 1 and Additional File 2). Direct com-
parisons of satisfaction scores between study samples
are problematic due to the diversity of assessment
instruments used, differences in client profiles, treat-
ment settings, interventions delivered and study designs.
While variability of satisfaction scores was low in most
studies, greater differences in ratings between clients
were found in the three UK-based studies, which addi-
tionally used the Treatment Perceptions Questionnaire
[28,29,52] (see Table 1). In another study where greater
variability in the overall mean satisfaction score was also
shown, the scale that was used covered several aspects
beyond treatment satisfaction, which complicates the
interpretation of the score range [41] (see Table 1 and
Additional File 2). Turning to the stability of client rat-
ings over time, those studies that assessed satisfaction at
multiple treatment stages (n = 10, see Additional File 2)
reported no significant changes in ratings across assess-
ment points. For one of these studies [30] though,
updates from a 30-month follow-up assessment were
published in which a trend of decreasing satisfaction
levels over time was reported [56]. It remained unclear
if this decline reached an acceptable level of statistical
significance as no probabilities were reported.
Do satisfaction levels among DD clients differ by type of
treatment model?
All seven studies that investigated associations between
type of treatment approach and satisfaction ratings
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compared a form of integrated DD treatment (i.e. simul-
taneous care for both the mental health and substance
misuse problems by the same provider) with standard
care models without specific DD focus
[30,31,37,38,41,44,52]. The range of specific interven-
tions and settings of the integrated treatment pro-
grammes differed to some extent across the seven
studies (e.g. depression- vs. trauma-focused care and
residential vs. assertive settings; see Table 2 and Addi-
tional File 2).
The earliest of these seven studies compared satisfac-
tion ratings of 42 male clients treated in a residential
integrated programme with 93 clients receiving residen-
tial addiction treatment only [37]. Participants provided
satisfaction ratings one month after treatment discharge.
Information about clients’ average length of treatment
stay was not reported. Results showed that the majority
(88%) of clients in the integrated treatment programme
were satisfied with their care (46% = ‘very satisfied’, 42%
= ‘somewhat satisfied’). Similar overall satisfaction rates
were found in the comparison group (85%), but here less
than one quarter (23%) said they were ‘very satisfied’ and
almost two thirds (62%) reported being ‘somewhat satis-
fied’ (see Additional File 2). The lack of a standardised
satisfaction measure means that the results cannot easily
be compared with other studies. Despite reporting that
the differences found were statistically significant, the
author did not include relevant test results.
Table 1 Clients’ mean scores of treatment satisfaction ratings including standard deviation
Author Instrument (score range) Mean score Standard Deviation
Afuwape et al. (2006) [28] CSQ-8 (8-32)
TPQ (0-40)
CSQ-8: 21.5-21.5, TPQ: 19.9-23.8 CSQ: 5.3-6.9; TPQ: 5.2-7.2
Aguilera et al. (1999) [38] Unknown measure (not applicable1) 9.6 Not reported
Anderson (1999) [37] Unknown measure (not applicable1) Not reported; 85-88% somewhat to very satisfied Not reported
Boden & Moos (2009) [36] Modified CSQ (0-33) 25.2-26.7 5.4-6.3
Brown et al. (2007) [43] Self-developed scale (-3 to +3) 2.3-2.7 0.7-0.9
Burns et al. (2005) [33] Self-developed scale (1-4) 2.7-2.8 Not reported
Clark et al. (2008) [41] CSQ-8 (8-32); CPC (26-104) CPC: 76.7; CSQ: not reported CPC: 12.4; CSQ: not
reported
Covington et al. (2008)
[42]
CSQ-8 (8-32) Not reported; 92% positive to very positive
ratings
Not reported
Craig et al. (2008) [52] CSQ-8 (8-32); TPQ (0-40) CSQ-8: 22.8-23.5; TPQ: 20.1-21.5 CSQ: 5.7-6.5; TPQ: 0.8-8.6
Daughters et al. (2008)
[44]
Modified CSQ (8-32) 24.6-27.6 2.8
Godley et al. (2000) [47] Self-developed scale (1-5) 4.2-4.3 0.6
Harrison et al. (2008) [48] Self-developed scale (not reported) Not reported; 92% satisfied to very satisfied Not reported
Herrell et al. (1996) [35] Self-developed scale (1-7) 4.8-5.1 Not reported
Magura et al. (2008) [53] Self-developed scale (0-10) 7.5 2.7
McHugo et al. (1999) [49] Modified Lehman’s QOL Interview (1-
7)
4.9-5.2 0.9-1.2
Miles et al. (2003) [29] CSQ-8 (8-32); TPQ (0-40) CSQ: 21.7-23.7; TPQ: 18.5-22.6 CSQ: 4.8-6.6; TPQ: 6.8-8.9
Miles et al. (2007) [39] Self-developed scale (not reported) Not reported; 88-100% satisfied Not reported
Moore et al. (2009) [50] Self-developed scale (not reported) Not reported; 75-90% satisfied to very satisfied Not reported
Morse et al. (2006) [30] Self-developed scale (1-6) 4.7-5.2 0.7-1.0
Morse et al. (2008) [31] Self-developed scale (1-6) 4.2-5.1 0.4-1.1
Najavits et al. (1998) [40] Modified CSQ (1-4) 3.0-3.1 0.4
Pollack et al. (1997) [54]] CSQ-8 (8-32) 27.5 0.7-0.9
Primm et al. (2000) [32] CSQ-8 (8-32) 24.7-28.3 1.9-4.5
Prince (2005) [34] Self-developed scale (1-4) Not reported; > 89% satisfied Not reported
Ries et al. (1999) [46] Modified CSQ (4-20) 16.6 0.9-1.1
Shaner et al. (2003) [45] Self-developed scale (1-5) Not reported; scores of > 4 on all items Not reported
Wise (2010) [50] CSQ-8 (8-32) 29.6 Not reported
Key: CSQ-8 = Client Satisfaction Questionnaire (8 items), TPQ = Treatment Perceptions Questionnaire, CPC = Consumer Perceptions of Care, QOL = Quality of Life.
For more details about all instruments, see Additional File 2.
1 20 Fill-in-the-blank questions were used.
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The same author was part of a research team that
replicated the above-mentioned study in Honduras [38].
Here, 40 male DD clients based in residential integrated
treatment were compared with 46 clients treated in a
residential drug/alcohol programme on a range of out-
come variables including satisfaction. The satisfaction
assessment took place three months after treatment
intake or upon successful completion and discharge
from the programme. The authors reported identical
average satisfaction scores for both treatment groups
(see Table 1 and Additional File 2).
In a large multi-site study [41] 1,415 female clients were
provided with integrated trauma-focused treatment, com-
pared to 1,314 participants who received standard care. At
the 3- and 6-month follow-up assessments, the interven-
tion group had significantly higher satisfaction ratings
than the controls (see Table 2 and Additional File 2). The
study used a newly developed measure to assess client
views. This instrument had high internal consistency (a>
0.9) and was moderately correlated with the CSQ-8 (r =
0.56, p < 0.001, n = 121). However, clients’ satisfaction
scores on the CSQ-8 were not reported separately.
Similar findings were shown by a smaller recent study
[44], which compared 22 DD clients who received two
weeks of integrated inpatient care with a DD control
group (n = 22) provided with standard drug/alcohol
treatment. All participants were randomly allocated to
the two treatment interventions and satisfaction was
assessed after a treatment stay of five weeks. The inter-
vention group reported significantly higher satisfaction
levels (see Table 2). In sum, all but one of the above-
mentioned studies showed that DD clients receiving
integrated care were more satisfied than the comparison
groups in standard treatment.
The other three studies that compared satisfaction
levels between DD clients who were provided with
Table 2 Satisfaction levels among dual diagnosis clients by type of treatment model
Author Sample Treatment
intervention
Control condition Satisfaction levels between groups Treatment fidelity
Aguilera et al.
(1999) [38]
N = 86
Main DD: mood
disorder + polydrug
misuse
DD
treatment
(n = 40)
Drug/alcohol
treatment
(n = 46)
No difference in treatment satisfaction
scores. Results of statistical tests not
reported.
Not reported
Anderson
(1999) [37]
N = 225
Main DD: psychosis +
polydrug misuse
DD
treatment
(n = 76)
Drug/alcohol
treatment
(n = 149)
Higher satisfaction levels among
intervention group
(n = 42) but relevant tests not reported.
Not reported
Clark et al.
(2008) [41]
N = 2,729
Main DD: unspecified
+ history of trauma
Trauma-
focused DD
treatment
(n = 1,415)
Mental health or
drug/alcohol
treatment
(n = 1,314)
Intervention group had higher
satisfaction scores at follow-ups
(3-month: F = 8.77, p < 0.01; 6-month: F
= 4.07, p < 0.05).
Not reported
Craig et al.
(2008) [52]
N = 232
Main DD: psychosis +
alcohol misuse
DD
treatment
(n = 127)
Mental health
treatment
(n = 105)
No significant differences in satisfaction
levels
(CSQ: p = 0.39, TPQ: p = 0.62).
Not reported
Daughters et al.
(2008) [44]
N = 44
Main DD: mood and
anxiety disorders +
cocaine misuse
Depression-
focused DD
treatment
(n = 22)
Drug/alcohol
treatment
(n = 22)
The intervention group reported
significantly higher satisfaction levels (p
< 0.01).
High levels of treatment
fidelity (mean = 7.3 on 9-
point Likert scale).
Morse et al.
(2006) [30]
N = 149
Main DD:
schizophrenia +
alcohol misuse
Assertive DD
treatment
(IACT; n =
46)
1. Assertive mental
health treatment
(ACTO; n = 54)
2. Standard mental
health or drug /
alcohol treatment
(SC; n = 49)
Clients in the IACT and ACTO
programme were significantly more
satisfied than SC clients
(p = 0.03). 1, 2
Treatment diffusion
between IACT and ACTO.
3
Morse et al.
(2008) - based
on [30] - [31]
N = 270
Main DD:
schizophrenia +
alcohol misuse
New
assertive DD
treatment
(NIACT; n =
79)
1. IACT (n = 61)
2. ACTO (n = 65)
3. SC (n = 65)
Clients in the NIACT programme were
significantly more satisfied than clients
in the other 3 programmes
(p < 0.001).
High level of treatment
fidelity in the NIACT
model. 4
Key: DD = dual diagnosis
1 No significant differences in satisfaction levels between the IACT and ACTO groups (no statistics reported). No main effect of time (p = 0.32).
2 Updated findings of this study were published by Fletcher et al. (2008) including results from additional satisfaction assessments: 3 months: IACT = 5.10 (0.72),
ACTO = 5.23 (0.84), SC = 4.76 (1.06), 15 months: IACT = 4.79 (1.18), ACTO = 5.10 (1.16), SC = 5.00 (0.95), and 30 months: IACT = 4.20 (0.35), ACTO = 4.15 (0.52), SC
= 4.36 (0.38).
3 Treatment fidelity of different service components was measured using 5-point Likert scales. Treatment diffusion between IACT and ACTO: substance abuse
components were only partially implemented in IACT, evidence of addiction-focused interventions and DD training in ACTO.
4 Mean fidelity scores ranged from 3.9-4.1 using 5-point Likert scales (same as in Morse et al. 2006).
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either integrated or standard care were conducted in
outpatient treatment settings. The most recent study
took place in the UK and had the advantage of using
two different satisfaction measures (see Additional File
2) [52]. The authors examined whether clients (n = 45)
treated in an integrated fashion by practitioners with
DD training were more satisfied than clients (n = 86)
provided with community mental health treatment by
non-trained practitioners. No differences in satisfaction
levels between the two client samples were found at
the18-month follow-up assessment (see Table 2).
In contrast, a US study [30] showed that 46 DD cli-
ents treated by staff who had received training in deli-
vering assertive integrated treatment were significantly
more satisfied than 49 clients treated in general non-
assertive addiction or mental health programmes. This
difference was evident throughout four assessment
points between six and 24 months after treatment initia-
tion and was maintained at the recently reported 30-
month assessment [56]. Nevertheless, satisfaction ratings
were very similar in the assertive DD-focused treatment
condition and a third comparison group (n = 54) of
assertive mental health-focused treatment (see Table 2
and Additional File 2). Hence, study results might sug-
gest that participants who received assertive treatment
had higher satisfaction levels than participants in a non-
assertive treatment programme regardless of whether or
not there was a DD focus. At the same time however,
the authors noted that some treatment overlap occurred
between the DD and mental health-focused assertive
treatment conditions during the study period. That is,
the two programmes were less distinct than intended
(i.e. substance abuse components were only partially
implemented in the integrated treatment group and
there was evidence of addiction-focused interventions
and DD training in the mental health programme).
Therefore, it is possible that the lack of differences in
satisfaction ratings between those two programmes is
due to the actual treatment provided being quite similar.
This assumption is supported by findings from a study
that built upon and extended the above-mentioned
approach [31]. Here, a new assertive integrated treatment
condition was added, in which 79 clients were provided
with extra addiction-focused services aiming to achieve
higher treatment fidelity. Clients in this fourth treatment
group reported significantly greater satisfaction at three
and 15 months after intake than clients in the other two
assertive treatment programmes and the control condi-
tion (p < 0.001, see Table 2 and Additional File 2).
The assessment of treatment fidelity by measuring the
extent to which interventions were implemented as
intended is a particular strength of the two studies con-
ducted by Morse and colleagues [30,31]. Apart from the
previously mentioned study by Daughters et al. [44],
where therapists’ adherence to the treatment manual
was monitored and confirmed to be high, none of the
other studies that compared satisfaction in DD clients
by treatment type reported data on treatment fidelity
(see Table 2). Another strength of these three studies is
that clients were randomly allocated to the different
treatment conditions. In contrast, client selection biases
due to non-randomization have to be considered in the
other four studies described in this section.
Are DD clients less satisfied compared to non-DD clients
when treated in the same clinical setting?
Three studies were identified that addressed this ques-
tion (see Table 3 and Additional File 2). In a recent
large US study [36], treatment satisfaction with a resi-
dential drug/alcohol programme was measured in male
clients with and without co-morbid problems (n = 691
and n = 1,805, respectively). The authors reported that
DD clients were significantly less satisfied with treat-
ment than the comparison group at discharge.
In contrast, two earlier smaller-scale studies had
shown no significant differences: In a US study, severely
mentally ill clients in a residential mental health facility
were classified either as having DD problems (n = 24)
or suffering from mental illness only (n = 68) [35]. Sev-
eral measurements were taken pre- and post-treatment
(approximate treatment length was three weeks) includ-
ing client satisfaction after discharge. The non-DD sam-
ple had a slightly higher mean satisfaction score than
the DD group, but the difference was not statistically
significant (see Table 3 and Additional File 2). Similarly,
an Australian study carried out in two drug/alcohol out-
patient programmes asked 71 participants to provide
satisfaction ratings three months after treatment intake
[33]. Again, results showed no statistically significant
differences in satisfaction scores between DD (n = 48)
and non-DD clients (n = 23; see Table 3 and Additional
File 2). No power calculations were reported and these
two studies may have been too small to detect moderate
group differences.
Other factors linked to treatment satisfaction among DD
clients
Several studies reported investigating associations
between satisfaction, client and treatment-related factors
in their DD samples. The selection of test variables (e.g.
clients’ gender, frequency of service contacts) differed
across studies hence complicating direct comparisons.
Studies that examined client socio-demographics found
no link between gender, age, education, employment,
marital status or ethnicity and treatment satisfaction
[28,34,41,54]. Similarly, there were no associations
between primary substance used or type of psycho-
pathology and satisfaction [29,34].
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A number of studies examined associations between
satisfaction and other treatment-related variables. One
study found a weak but significant positive relationship
between greater satisfaction levels, clients’ own outcome
ratings (r = 0.3, p < 0.05) and case managers’ evaluations
of clients’ progress (r = 0.3, p < 0.05) [46]. Another study
reported that provision of staff assistance to clients’
family members in coping with the individuals’ mental
illness significantly increased treatment satisfaction (OR
= 6.91, p < 0.05) [34]. No programme-specific analyses
were mentioned by the authors (i.e. satisfaction ratings in
programmes with family assistance vs. programmes with-
out family assistance) but an effect was apparent at the
client level (i.e. all clients who received such assistance
from any of the programmes were more satisfied). More
recently it was shown that satisfaction was associated
with clients’ ratings of the treatment’s usefulness for their
recovery (r = 0.6, p < 0.05) [53]. Furthermore, this study
found both satisfaction and treatment usefulness ratings
to be correlated with another variable referred to as
‘Changes in Recovery Behaviours’ (e.g. reduced substance
use, taking psychiatric medications, self-care; multiple R
= 0.3, p < 0.05). Findings from these studies need to be
considered carefully though, as it remained unclear
whether or not other potentially confounding variables
(e.g. client motivation, therapeutic alliance) were
included in the analyses.
Nevertheless, the results above are partially supported
by a well-controlled study [56] which found that treat-
ment satisfaction was positively influenced - though to a
varying extent over time - by the intensity of help with
activities of daily living, help with emotional problems
and transportation assistance. Further variables asso-
ciated with satisfaction were the frequency of contact
with the programme in general and the number of ser-
vice contacts where substance misuse issues were
addressed specifically [56]. All mentioned variables were
linked to higher treatment satisfaction across the three
treatment programmes included in the study (i.e. after
controlling for treatment condition).
Moving from treatment process to outcome variables,
one study demonstrated the positive effect of client
satisfaction on clinical outcomes, including reduced
substance misuse problems and psychiatric symptom
severity at both 1- and 5-year follow-ups, after control-
ling for a range of potential confounders [36].
Discussion
Over the last four decades, 27 studies meeting our
inclusion criteria could be identified that examined
treatment satisfaction in DD clients. This review shows
that most DD clients report being satisfied with their
treatment experience, reflected by average ratings close
to the “satisfied” end of the scales used. This applied
regardless of the differences in study location (i.e. US,
UK, Australia or Honduras), treatment settings and
types of interventions delivered. When comparing satis-
faction ratings of dual and single diagnosis clients trea-
ted in the same setting (i.e. either mental health or
substance misuse treatment), a large and well-designed
study found that DD clients were significantly less satis-
fied than single diagnosis clients [36]. Two smaller stu-
dies, however, showed that clients with co-morbid
problems had similarly high satisfaction ratings as those
with a single diagnosis [33,35]. This inconsistency may
be linked to differences in satisfaction instruments used
(i.e. standardised vs. non-standardised), client profiles
(e.g. the larger study included men only) and the small
sample sizes in the two studies that found no differences
in satisfaction ratings (N < 50).
If replicated in future studies, a finding that DD cli-
ents are less satisfied with standard (i.e. either mental
health or addiction-focused) treatment than single diag-
nosis clients would support the common understanding
that disease-specific treatment is inadequate to address
the complex needs of the DD population. An integrated
treatment model is usually favoured in discussions
about which approach is the most beneficial for co-mor-
bid clients e.g. [57,58]. The question as to whether or
not these benefits are also reflected in greater
Table 3 Satisfaction levels among DD and non-DD clients in same treatment setting
Author Treatment
setting
Total
sample
DD clients Non-DD clients Satisfaction levels between groups
Boden &
Moos
(2009)
[36]
Drug/alcohol
programme
N =
2,496
n = 691
Main DD: mood disorder + alcohol
misuse
n = 1,805
Problem area:
alcohol misuse
DD clients were significantly less satisfied
with treatment
(F = 27.9, p < 0.01).
Burns et al.
(2005)
[33]
Drug/alcohol
programme
N = 71 n = 48
Main DD: mood disorder + alcohol
misuse
n = 23
Problem area:
alcohol misuse
No significant differences in satisfaction
scores between groups
(t = -0.41, p = 0.15).
Herrell et al.
(1996)
[35]
Mental health
programme
N = 92 n = 24
Main DD: mood disorder +
unspecified substance misuse
n = 68
Problem area:
mood disorder
No significant differences in satisfaction
scores between groups
(t = 1.14, p > 0.25).
Key: DD = dual diagnosis
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satisfaction levels was specifically addressed by seven
studies included in this review. Of these, five offered evi-
dence that integrated care yields greater client satisfac-
tion than standard treatment [30,31,37,41,44]. The five
studies were all conducted in the US whereas the two
other studies that found no significant differences in
satisfaction by treatment approach were carried out else-
where (UK and Honduras ) [38,52]. In this context,
however, it is important to bear in mind that of the
seven studies identified only three assessed treatment
fidelity and thus monitored if the integrated treatment
condition was implemented as intended. These three
studies consistently demonstrated higher satisfaction
levels in the integrated treatment group compared to
ratings from clients in standard care [30,31,44].
Nine studies investigated which factors - other than
treatment type - are associated with satisfaction among
DD clients. Studies that examined client pre-treatment
factors (i.e. demographics, primary substance of misuse
and type of psychopathology) found no association with
satisfaction ratings. In contrast, a number of treatment
process and service-related variables were identified that
appeared linked to satisfaction (e.g. client and staff out-
come ratings, frequency of contact with treatment ser-
vice, family and transportation assistance). In some
studies though, it remained unclear whether or not
potential confounders were taken into account, which
needs to be addressed in future studies. Moreover, it
would be important to examine the effect of variables
that have been found to be associated with treatment
satisfaction among single diagnosis samples in the past
(e.g. access routes, treatment motivation and engage-
ment, care-plan procedures, staff and service character-
istics) [11,59-65].
In terms of rigor, the 27 studies were diverse, and
some had important methodological shortcomings. Only
13 studies used standardised measures to assess treat-
ment satisfaction, and while the selected instruments
have shown acceptable psychometric properties when
used with single diagnosis treatment populations e.g.
[11,55,66,67], the scales’ reliability and validity in clients
with co-morbidity was reported by only two studies
[36,41]. DD clients might have different treatment
expectations due to more complex needs than those
with a single diagnosis. Thus, response patterns to a
given set of questions might vary between populations
with and without DD, and psychometric testing would
be important to ensure meaningful interpretation of
data. Similarly, only three of the studies that used a self-
developed satisfaction scale provided psychometric
information sufficient to permit reasonable evaluation of
the instruments [30,31,51].
Secondly, studies were restricted in their examination
of potential confounders of satisfaction ratings. Only five
studies reported explicitly that they controlled for any
links between client characteristics and satisfaction levels
[28,34,36,41,54]. The lack of client control variables and
other potential confounders (e.g. treatment process vari-
ables, practitioner characteristics) is of particular concern
in those studies that compared satisfaction levels by type
of treatment model: uncontrolled factors may affect cli-
ents’ satisfaction ratings, which in turn distorts interpre-
tations concerning actual treatment effects.
A third methodological difficulty concerns possible
time-in-treatment effects on satisfaction ratings. In most
of the reviewed studies, clients were at different treat-
ment stages when satisfaction was assessed, with only
ten studies taking the length of treatment exposure into
account. Two of these reported client satisfaction at dif-
ferent treatment stages, with one showing stable high
ratings throughout [40] and the other study indicating a
negative linear trend in satisfaction levels during the
treatment course [56]. Based on the latter, it could be
assumed that clients’ most urgent needs are addressed
in the early treatment phase thus producing particularly
high satisfaction levels early on in the programme. In
later treatment phases though, possibly more persistent
problem areas are targeted for which behaviour change
and improvement is more difficult to achieve. Subse-
quently, studies examining satisfaction early in treat-
ment may find higher satisfaction ratings than studies
with later assessment schedules. However, at the same
time it is plausible that clients who have spent more
time in treatment may have experienced greater benefits
overall and possibly show higher satisfaction levels than
clients who have spent less time in the programme [68].
In either case, having more information about potential
time-in-treatment effects across the existing studies
would have been useful.
The current review has highlighted some important gaps
in our knowledge of treatment satisfaction among DD cli-
ents such as the influence of practitioner characteristics
and treatment process variables as well as the effect of cli-
ent satisfaction on different treatment outcomes. Clients’
subjective evaluations have been recognised in both men-
tal health and addiction treatment populations as key indi-
cators of treatment quality and effectiveness e.g.
[19,21,36,69], and so this remains an important area of
research. The review contributes a methodological frame-
work of four key aspects that future studies should con-
sider to overcome the limitations, namely: 1) employment
of well-validated and comparable satisfaction assessment
techniques, 2) selection of multiple measures that incorpo-
rate several treatment- and client-related factors, 3) con-
trolling for potential confounders of satisfaction, including
pre- and in-treatment factors (e.g. treatment readiness, fre-
quency of service contact, substitute prescribing) and prac-
titioner characteristics (e.g. work experience), and 4) the
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nature and extent of treatment exposure (e.g. assertive vs.
standard care, length of treatment stay). Here, special
attention should be paid to the assessment of treatment
fidelity. This is particularly important for studies aiming to
replicate the finding that integrated treatment - if imple-
mented appropriately - yields greater client satisfaction
than other treatment models. Furthermore, it would be
vital for future studies to investigate links between satisfac-
tion and other treatment process and outcome variables to
demonstrate more clearly whether greater satisfaction
among DD clients translates into better engagement and
retention, lower relapse rates and reduced symptom sever-
ity. Finally, a more general point requires consideration: a
recent review has shown that satisfaction studies dispro-
portionally found positive accounts from clients through-
out treatment modalities and client populations [70]. In
order to avoid misinterpretation of client ratings due to
social desirability or other potential bias, safeguards should
be applied in future studies, such as keeping assessments
anonymous and comparing satisfaction ratings of treat-
ment completers and dropouts.
A limitation of the current review is that no meta-ana-
lysis could be carried out. A quantitative synthesis of
data could have taken into account small sample sizes
and moderate - if not significant - effects thus providing
further insight into the current evidence base. Depend-
ing on the growth of studies in this field, future reviews
should include such analyses where possible.
Conclusions
Our review shows that dually diagnosed clients are, on
the whole, satisfied with current treatment provision,
despite the common notion that individuals with co-
morbidity are the most difficult-to-treat clients e.g. [71].
Integrated treatment delivery, which simultaneously
addresses both addiction and mental health concerns,
appeared to result in particularly high levels of satisfac-
tion. Findings should be of particular interest to treat-
ment providers as it may enhance optimism among
practitioners dealing with such clients.
Additional material
Additional File 1: Studies on dual diagnosis clients and treatment
satisfaction that were excluded after full-text retrieval. Shows full
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Additional File 2: Overview of studies assessing treatment
satisfaction among dually diagnosed clients. Shows key characteristics
of all studies included in the review
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